Market trends · on the rundown Tuesday, March 10, 2026
Analysis finds 35% decline in antimicrobial R&D at large drugmakers over 5 years.
Covered by 1 outlet. First reported by STAT News at 10:00 UTC on March 10, 2026.
- outlets1
- distinct reports1
- first to latest report0 h
- names in it0
What happened?
- The number of antimicrobial treatments in development by large drugmakers fell 35% over the last five years.
- Large drugmakers are developing fewer antibiotics, an analysis found.
A new analysis reveals a 35% decline in antimicrobial R&D among the world's largest pharmaceutical companies over the last five years. Large drugmakers are developing fewer antibiotics, according to an analysis.
A machine summary written from the reports listed below; read them for the full account. How summaries are made and what is checked.
Who reported it, and when?
| Time | Report | Run by |
|---|---|---|
| Mar 10 10:00 | STAT+: Large drugmakers are developing fewer antibiotics, analysis finds |
|
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).